News | September 15, 2022
AstraZeneca launches up-skilling program iPHARMACY
The company has partnered with Neethi, a Kerala state cooperative consumers federation limited company, to run this program in Kerala
The company has partnered with Neethi, a Kerala state cooperative consumers federation limited company, to run this program in Kerala
They also noted ProBioGen's digitalization investments and strategy, as well as its support for its employees.
He takes over leadership of Cell & Gene from Jean-Christophe Hyvert, enabling Jean-Christophe to increase his focus on his role as President of the Biologics Division
Orelabrutinib is a highly selective BTK inhibitor developed by InnoCare for the treatment of cancers and autoimmune diseases.
Phase 1 dose-escalation study to be conducted at clinical sites in the U.S., the UK, Australia, and the Philippines
The Trial, the first of its kind in Israel, recently obtained approval from the Israeli Ministry of Health and is preparing for participant recruitment.
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines
She joins Enveda from Gilead Sciences
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
Subscribe To Our Newsletter & Stay Updated
